ArticleAmerican journal of translational research2021

High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.

Chuanhui Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.